Alpa Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

Revenue DeclineResults View source PDF Explain this filing

ALPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-7.1%Reaction day

₹112.50

prior close

₹110.98

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-7.5% vs market

Pharmaceuticals peers, median of 147sector+0.5%-7.6% vs sector

On the reaction day the stock moved 7.5 pts less than Nifty Microcap 250 and 7.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.5

10m

-4.3

15m

-5.1

30m

-4.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-7.1+0.4-7.5+0.5-7.6

Next day

-12.2+0.7-12.8-0.2-12.0

-11.6+0.7-12.4-0.3-11.3

-9.5+0.5-10.0-0.4-9.1

-10.5+1.0-11.5-0.1-10.4

-12.0+1.5-13.5-0.1-11.9

-11.1+2.8-13.9+0.5-11.6

15d

-14.2-0.7-13.5-2.8-11.4

-7.2+3.7-10.9+0.2-7.4

-7.5+3.0-10.5+1.4-8.9

-16.1-1.4-14.7-4.0-12.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alpa Laboratories Limited has submitted its audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, with an unmodified auditor opinion from C.H. Padliya & Co. On a standalone basis, FY25 revenue from operations rose modestly to ₹11,164.49 lakhs (FY24: ₹10,873.90 lakhs, +2.7%), but profit after tax fell to ₹1,677.77 lakhs from ₹1,967.94 lakhs (-14.7%), weighed down by weak Q4 performance. Consolidated FY25 PAT, however, improved to ₹1,950.31 lakhs from ₹1,677.65 lakhs (+16.3%). Q4 standalone revenue dropped sharply to ₹2,360.66 lakhs from ₹3,911.23 lakhs a year ago. The Board also approved the appointment of new Secretarial, Internal, and Cost Auditors.

Likely market impact

Mixed bag for shareholders — full-year numbers are broadly stable, but the steep Q4 revenue and profit decline could weigh on short-term sentiment. The simultaneous change of three auditors is a governance point worth noting.